Chris Day

6.1k total citations · 2 hit papers
54 papers, 4.3k citations indexed

About

Chris Day is a scholar working on Epidemiology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chris Day has authored 54 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 18 papers in Pathology and Forensic Medicine and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chris Day's work include Liver Disease Diagnosis and Treatment (39 papers), Alcohol Consumption and Health Effects (18 papers) and Diet, Metabolism, and Disease (14 papers). Chris Day is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Alcohol Consumption and Health Effects (18 papers) and Diet, Metabolism, and Disease (14 papers). Chris Day collaborates with scholars based in United Kingdom, Italy and Australia. Chris Day's co-authors include Giulio Marchesini, Stefano Bellentani, Alastair D. Burt, Vlad Ratziu, Helena Cortez‐Pinto, Luca Miele, Antonio Grieco, Antonio Gasbarrini, Venanzio Valenza and Germano Perotti and has published in prestigious journals such as The Lancet, Analytical Chemistry and Hepatology.

In The Last Decade

Chris Day

52 papers receiving 4.2k citations

Hit Papers

Increased intestinal permeability and tight junction alte... 2009 2026 2014 2020 2009 2010 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†
    2009 1.1k citations Chris Day et al. Hepatology profile →
  2. A position statement on NAFLD/NASH based on the EASL 2009 special conference
    2010 828 citations Vlad Ratziu, Stefano Bellentani et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Day United Kingdom 23 3.4k 1.5k 1.1k 1.0k 965 54 4.3k
Cláudia P. Oliveira Brazil 36 3.0k 0.9× 1.1k 0.8× 1.5k 1.4× 754 0.8× 398 0.4× 145 4.3k
Gabriel Perlemuter France 36 3.3k 1.0× 815 0.6× 1.9k 1.7× 1.6k 1.6× 946 1.0× 112 5.5k
Antonio Grieco Italy 38 3.9k 1.2× 1.4k 0.9× 2.1k 1.9× 1.5k 1.5× 764 0.8× 225 6.5k
Nicola Villanova Italy 23 3.2k 0.9× 1.8k 1.3× 899 0.8× 506 0.5× 633 0.7× 40 4.3k
Dae Won Jun South Korea 37 3.1k 0.9× 1.1k 0.8× 1.5k 1.3× 1.0k 1.0× 514 0.5× 290 5.3k
Stefano Ballestri Italy 32 4.5k 1.3× 2.3k 1.6× 1.6k 1.4× 734 0.7× 823 0.9× 54 5.3k
Fabio Nascimbeni Italy 28 4.1k 1.2× 2.2k 1.5× 1.5k 1.4× 594 0.6× 785 0.8× 54 4.8k
Rita Manini Italy 14 2.9k 0.9× 1.8k 1.2× 708 0.6× 497 0.5× 544 0.6× 18 3.5k
Laura Wilson United States 34 4.9k 1.4× 2.0k 1.4× 1.9k 1.7× 744 0.7× 692 0.7× 105 6.4k
Mariana Verdelho Machado Portugal 36 4.9k 1.5× 1.9k 1.3× 1.8k 1.6× 2.1k 2.1× 644 0.7× 90 6.7k

Countries citing papers authored by Chris Day

Since Specialization
Citations

This map shows the geographic impact of Chris Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Day more than expected).

Fields of papers citing papers by Chris Day

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Day. The network helps show where Chris Day may publish in the future.

Co-authorship network of co-authors of Chris Day

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Day. A scholar is included among the top collaborators of Chris Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Day. Chris Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Brial, François, Lyamine Hedjazi, Jane Fearnside, et al.. (2019). Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment. Scientific Reports. 9(1). 3656–3656. 10 indexed citations
5.
Salawu, Abdulazeez, Malee Fernando, David J. Hughes, et al.. (2016). Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines. British Journal of Cancer. 115(9). 1058–1068. 31 indexed citations
6.
Anderson, Emma L., Laura D Howe, Abigail Fraser, et al.. (2014). Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: The ALSPAC study. Journal of Hepatology. 61(3). 626–632. 108 indexed citations
7.
Lawlor, Debbie A., Diana L. Santos Ferreira, Alun D. Hughes, et al.. (2014). The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence. Journal of Hypertension. 33(3). 546–553. 12 indexed citations
8.
Day, Chris. (2013). Düşünce ve Hareketi Birleştirmek: Öğretmenler İçin Kişisel Gelişim Planlaması. DergiPark (Istanbul University). 1 indexed citations
9.
Kendrick, Stuart & Chris Day. (2013). Natural history and factors influencing the course of alcohol-related liver disease. Clinical Liver Disease. 2(2). 61–63. 4 indexed citations
10.
Targher, Giovanni, Giacomo Zoppini, Paolo Moghetti, & Chris Day. (2010). Disorders of Coagulation and Hemostasis in Abdominal Obesity: Emerging Role of Fatty Liver. Seminars in Thrombosis and Hemostasis. 36(1). 41–48. 53 indexed citations
11.
Ratziu, Vlad, Stefano Bellentani, Helena Cortez‐Pinto, Chris Day, & Giulio Marchesini. (2010). A position statement on NAFLD/NASH based on the EASL 2009 special conference. Journal of Hepatology. 53(2). 372–384. 828 indexed citations breakdown →
12.
Kendrick, Stuart, Elsbeth Henderson, Jeremy M. Palmer, David E.J. Jones, & Chris Day. (2010). Theophylline Improves Steroid Sensitivity in Acute Alcoholic Hepatitis. Hepatology. 52(1). 126–131. 22 indexed citations
13.
14.
Daly, Ann K. & Chris Day. (2009). Genetic Association Studies in Drug-Induced Liver Injury. Seminars in Liver Disease. 29(4). 400–411. 65 indexed citations
15.
Loria, Paola, Amedeo Lonardo, Stefano Bellentani, et al.. (2007). Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question. Nutrition Metabolism and Cardiovascular Diseases. 17(9). 684–698. 67 indexed citations
16.
Day, Chris, Julian Leathart, Philip G. McTernan, Christopher G. Mathew, & Ann K. Daly. (2006). Genetic evidence for a role for gut flora in the pathogenesis of NASH in humans. Hepatology. 44(4). 8 indexed citations
17.
Day, Chris. (2006). Genes or environment to determine alcoholic liver disease and non‐alcoholic fatty liver disease. Liver International. 26(9). 1021–1028. 124 indexed citations
18.
Adams, David, Geoffrey Haydon, & Chris Day. (2006). Non-alcoholic fatty liver disease: current concepts and management strategies. Clinical Medicine. 6(1). 19–25. 118 indexed citations
19.
Day, Chris, et al.. (2002). Genetic evidence supporting the two-hit model of NASH pathogenesis. Hepatology. 4 indexed citations
20.
Day, Chris & M.F. Bassendine. (1992). Genetic predisposition to alcoholic liver disease.. Gut. 33(11). 1444–1447. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cláudia P. Oliveira Breakdown of academic impact, for papers by Gabriel Perlemuter Breakdown of academic impact, for papers by Antonio Grieco Breakdown of academic impact, for papers by Nicola Villanova Breakdown of academic impact, for papers by Dae Won Jun Breakdown of academic impact, for papers by Stefano Ballestri Breakdown of academic impact, for papers by Fabio Nascimbeni Breakdown of academic impact, for papers by Rita Manini Breakdown of academic impact, for papers by Laura Wilson Breakdown of academic impact, for papers by Mariana Verdelho Machado
Rankless by CCL
2026